bradykinin, leu(8)-des-arg(9)- has been researched along with chelerythrine in 1 studies
Studies (bradykinin, leu(8)-des-arg(9)-) | Trials (bradykinin, leu(8)-des-arg(9)-) | Recent Studies (post-2010) (bradykinin, leu(8)-des-arg(9)-) | Studies (chelerythrine) | Trials (chelerythrine) | Recent Studies (post-2010) (chelerythrine) |
---|---|---|---|---|---|
102 | 0 | 7 | 1,115 | 1 | 269 |
Protein | Taxonomy | bradykinin, leu(8)-des-arg(9)- (IC50) | chelerythrine (IC50) |
---|---|---|---|
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | Oryctolagus cuniculus (rabbit) | 1.2 | |
Cholinesterase | Homo sapiens (human) | 8.58 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.55 | |
Acetylcholinesterase | Homo sapiens (human) | 1.45 | |
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.566 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asada, A; Maeda, K; Nakamura, M; Watanabe, T; Yasunari, K; Yoshikawa, J | 1 |
1 other study(ies) available for bradykinin, leu(8)-des-arg(9)- and chelerythrine
Article | Year |
---|---|
Converting enzyme inhibitor temocaprilat prevents high glucose-mediated suppression of human aortic endothelial cell proliferation.
Topics: Alkaloids; Angiotensin-Converting Enzyme Inhibitors; Aorta; Benzophenanthridines; Bradykinin; Bradykinin B2 Receptor Antagonists; Cell Division; Cell Membrane; Cells, Cultured; Coronary Vessels; Dose-Response Relationship, Drug; Endothelial Cells; Glucose; Humans; Naphthalenes; Oxidative Stress; Phenanthridines; Protein Kinase C; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Thiazepines; Time Factors | 2003 |